Resmed Inc Revenue Growth Rates (RMD), Current and Historic Growth - CSIMarket
CSIMarket
 


Resmed Inc   (NYSE: RMD)
 

RMD's Revenue Growth by Quarter and Year

Resmed Inc 's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/RMD/growth
https://api.csimarket.com/api/v1/companies/RMD/fundamentals
https://api.csimarket.com/api/v1/companies/RMD/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
RMD Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September 1,441.81
FY 1,441.81

RMDs Annual Revenue
Resmed Inc 's Revenue in the fiscal year 2026 $ 5,653.44 millions
Resmed Inc 's Revenue in the fiscal year 2025 $ 5,113.97 millions
Resmed Inc 's Revenue in the fiscal year 2024 $ 4,652.30 millions
Resmed Inc 's Revenue in the fiscal year 2023 $ 4,191.66 millions
Resmed Inc 's Revenue in the fiscal year 2022 $ 5,092.29 millions




RMD Revenue first quarter 2026 Y/Y Growth Comment
Resmed Inc reported Revenue growth of 8.67% year on year in the first quarter 2026, to $ 1,441.81 millions, this is lower than Resmed Inc 's recent average Revenue improvement of 20.09%.

Looking into first quarter 2026 results within Medical Equipment & Supplies industry 123 other companies have achieved higher Revenue growth. While Resmed Inc ' s Revenue increase of 8.67% ranks overall at the positon no. 2323 in the first quarter 2026.




RMD Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September 8.67 %
FY   -

Financial Statements
Resmed Inc 's first quarter 2026 Revenue $ 1,441.81 millions RMD's Income Statement
Resmed Inc 's first quarter 2025 Revenue $ 1,326.82 millions Quarterly RMD's Income Statement


RMD Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September -1.49 %
FY (Year on Year)   -




Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #124
Healthcare Sector #336
Overall #2323

Revenue Y/Y Growth Statistics
High Average Low
213.28 % 20.09 % -20.79 %
(Sep 30 2014)   (Mar 31 2023)
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #124
Healthcare Sector #336
Overall #2323
Revenue Y/Y Growth Statistics
High Average Low
213.28 % 20.09 % -20.79 %
(Sep 30 2014)   (Mar 31 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Resmed Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
36.72 % 3.03 % -25.44 %
(Sep 30 2020)  


RMD's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Resmed Inc disclosed decrease in Revenue from the fourth quarter by -1.49% to $ 1,441.81 millions, from $ 1,463.65 millions achived in the previous reporting period.

But that's not important problem, as Resmed Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 56 other companies have achieved higher Revenue quarter on quarter growth. While Resmed Inc 's Revenue growth quarter on quarter, overall rank is 1378.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #57
Healthcare Sector #191
Overall #1378
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #57
Healthcare Sector #191
Overall #1378
Revenue Q/Q Growth Statistics
High Average Low
36.72 % 3.03 % -25.44 %
(Sep 30 2020)  


RMD's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Resmed Inc disclosed decrease in Revenue from the fourth quarter by -1.49% to $ 1,441.81 millions, from $ 1,463.65 millions achived in the previous reporting period.

But that's not important problem, as Resmed Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 56 other companies have achieved higher Revenue quarter on quarter growth. While Resmed Inc 's Revenue growth quarter on quarter, overall rank is 1378.


Resmed Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)
12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 5,743.16
Y / Y Revenue Growth (TTM) 9.93 %
Year on Year Revenue Growth Overall Ranking # 1510
Seqeuential Revenue Change (TTM) 2.04 %
Seq. Revenue Growth (TTM) Overall Ranking # 2366


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Resmed Inc 's cumulative twelve months Revenue were $ 5,743 millions, company would post below average annual Revenue growth of 2.04% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Resmed Inc 's Revenue growth from the 1463.65% growth in Jun 30 2026.

In the Healthcare sector 253 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1229 to 1510.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 127
Healthcare Sector # 254
Overall # 1510

Revenue TTM Y/Y Growth Statistics
High Average Low
52.5 %
11.33 %
-20.79 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 127
Sector # 341
S&P 500 # 2366
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Resmed Inc 's cumulative twelve months Revenue were $ 5,743 millions, company would post below average annual Revenue growth of -20.79% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Resmed Inc 's Revenue growth from the 1463.65% growth in Jun 30 2026.

In the Healthcare sector 253 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1229 to 1510.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 127
Healthcare Sector # 254
Overall # 1510

Revenue TTM Y/Y Growth Statistics
High Average Low
52.5 %
11.33 %
-20.79 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 127
Sector # 341
S&P 500 # 2366




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RMD's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
P3 Health Partners Inc 14.80%$ 14.798 millions
Msa Safety Inc14.72%$ 14.716 millions
Ensign Group Inc14.47%$ 14.471 millions
Abbott Laboratories14.46%$ 14.460 millions
Electrocore Inc 14.40%$ 14.404 millions
Allogene Therapeutics Inc 14.29%$ 14.286 millions
Tandem Diabetes Care Inc 14.26%$ 14.257 millions
Iradimed Corporation14.15%$ 14.154 millions
Apyx Medical Corp14.09%$ 14.093 millions
Incyte Corporation14.00%$ 13.999 millions
Aurinia Pharmaceuticals Inc 13.93%$ 13.926 millions
Indivior Pharmaceuticals Inc 13.74%$ 13.738 millions
Cryoport inc 13.54%$ 13.535 millions
Neuronetics Inc 13.35%$ 13.350 millions
Royalty Pharma Plc13.26%$ 13.263 millions
Evolus Inc 13.23%$ 13.235 millions
Privia Health Group Inc 13.19%$ 13.187 millions
Biocryst Pharmaceuticals Inc 13.11%$ 13.110 millions
U S Physical Therapy Inc12.90%$ 12.898 millions
Maravai Lifesciences Holdings Inc 12.78%$ 12.781 millions
Alphatec Holdings Inc 12.67%$ 12.670 millions
Harmony Biosciences Holdings inc 12.61%$ 12.609 millions
Medicinova Inc 12.35%$ 12.355 millions
Bionano Genomics Inc 12.34%$ 12.339 millions
Viemed Healthcare Inc 12.18%$ 12.180 millions
Ufp Technologies Inc 12.15%$ 12.154 millions
Innovage Holding Corp 12.14%$ 12.135 millions
Vertex Pharmaceuticals Inc11.85%$ 11.845 millions
Sanara Medtech Inc 11.67%$ 11.668 millions
Lemaitre Vascular Inc 11.51%$ 11.508 millions


About Resmed Inc Revenue Growth Rates (RMD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Resmed Inc (CIK 943819).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000943819-26-000089
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Resmed Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.